[ Price : $8.95]
The U.S. government steps into an ongoing Biologics Price Competition and Innovation Act dispute (Amgen v. Sandoz), contending tha...[ Price : $8.95]
FDA approves CSL Behrings Privigen [immune globulin intravenous (human), 10% liquid] for treating adults with chronic inflammatory...[ Price : $8.95]
FDA approvea a Nesher Pharmaceuticals ANDA for the first generic version of Genentechs Tamiflu (oseltamivir phosphate) for oral su...[ Price : $8.95]
FDA approves a UCB supplemental NDA for Briviact (brivaracetam) as monotherapy for partial-onset (focal) seizures in patients 16 y...[ Price : $8.95]
T2 Biosystems files a 510(k) for the T2Bacteria Panel that is designed to run on the companys T2Dx Instrument as a rapid diagnosti...[ Price : $8.95]
Federal Register Notice: FDA makes available a guidance on Gifts to FDA: Evaluation and Acceptance.[ Price : $8.95]
Federal Register Notice: FDA seeks comments on an information collection related to Medical Devices; Pediatric Uses of Devices; Re...[ Price : $8.95]
Federal Register Notice: FDA makes available a guidance entitled Bioequivalence: Blood Level Bioequivalence Study.